HIV, Syfilis, Hepatitis Combo

A combined STI screening panel testing for HIV 1/2, syphilis, and hepatitis B from a single blood draw. Covers the three most clinically significant blood-borne sexually transmitted infections in one affordable panel, with confidential digital results delivery.

HIV, syphilis, and hepatitis B are the three blood-borne sexually transmitted infections with the greatest long-term health implications, and all three can be asymptomatic for extended periods. Early detection is critical: HIV is manageable as a chronic condition with antiretroviral therapy when caught early, syphilis is fully curable with antibiotics in its primary and secondary stages, and hepatitis B can be monitored and managed to prevent progression to chronic liver disease. This combination panel screens all three from a single venous blood draw, making it a practical and affordable option for routine sexual health assessment. HIV testing uses a combination assay detecting both antibodies and antigen for earlier detection. Syphilis is screened via TPHA (Treponema pallidum haemagglutination assay), and hepatitis B is detected through surface antigen (HBsAg) testing. At EUR 97 for all three tests combined, this panel is well suited for individuals who want a comprehensive STI baseline, those who have had a new sexual partner, travellers returning from regions with higher prevalence, and anyone who simply wants the peace of mind that comes with knowing their current status. The walk-in, no-referral model removes the social friction that can sometimes deter people from seeking STI testing through their GP. Results are delivered digitally and confidentially.